VIARTRIL-S CAPSULE 500mg

国家: 马来西亚

语言: 英文

来源: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

有效成分:

Glucosamine Sulfate, Crystalline

可用日期:

MYLAN HEALTHCARE SDN. BHD.

INN（国际名称）:

Glucosamine Sulfate, Crystalline

每包单位数:

90 Capsules; 60 Capsules; 6 Capsules

厂商:

ROTTAPHARM LTD

资料单张

VIARTRIL
®
-S CAPSULE
Glucosamine sulfate (500mg)
1
_CONSUMER MEDICATION INFORMATION LEAFLET (RIMUP)_
WHAT IS IN THIS LEAFLET
1.
What Viartril
®
-S Capsule is used for
2.
How Viartril
®
-S Capsule works
3.
Before you use Viartril
®
-S Capsule
4.
How to use Viartril
®
-S Capsule
5.
While you are using it
6.
Side effects
7.
Storage and Disposal of Viartril
®
-S
Capsule
8.
Product Description
9.
Manufacturer
and
Product
Registration Holder
10.
Date of revision
WHAT VIARTRIL
®
-S CAPSULE IS USED FOR
Viartril
®
-S Capsule is used as an adjuvant
therapy for osteoarthritis (loss of cartilage
in the joints).
HOW VIARTRIL
®
-S CAPSULE WORKS
Viartril
®
-S
Capsule
contains
glucosamine sulfate as active ingredient.
Glucosamine
sulfate
provides
relief
to
joint disease by reducing joint swelling
and pain.
BEFORE YOU USE VIARTRIL
®
-S CAPSULE
-
_When you must not use it _
_ _
Do not take Viartril
®
-S Capsule if you
have:
•
hypersensitivity to glucosamine or
any
other
ingredients
of
this
medicine
(listed
in
Product
Description)
•
allergies to shellfish as the active
ingredient is obtained from seafood
(shellfish)
_ _
-
_Before you start use it _
_ _
_Pregnancy and lactation _
Do not take Viartril
®
-S Capsule if you
are pregnant, trying to get pregnant or
think you may be pregnant.
Do not take Viartril
®
-S Capsule if you
are breast-feeding. Ask your doctor or
pharmacist for advice before taking any
medicine.
Tell your doctor or pharmacist if you
have:
•
asthma
•
a
controlled
sodium
diet
(the
sodium content of this capsule is
151mg for 1500mg daily dose)
•
liver or kidney problems
•
diabetes
or
impaired
glucose
tolerance
•
another
joint
disease
which
may
require alternative treatments
-
_Taking other medicines _
_ _
Tell your doctor or pharmacist if you
are taking:
•
coumarinic
anticoagulants
(blood
thinner)
•
tetracyclines (antibiotics)
Pain
relief
or
anti-inflammatory
medicines can be taken together with
Viartril
®
-S Capsule.
Tell your doctor if you are taking any
other medicines, including a

产品特点

Page 01 of 02
L1075F
05/09/2022
▼ BLACK
--- KEYLINE ---SAFE TEXT AREA
01
Leaflet Viartril-S 500mg Caps MY
148 X 210 (folded 148 X 26) mm
Helvetica Neue (7 pt)
N/A
N/A
D. Stancul
PART NUMBER:
DATE:
PHARMACODE:
BARCODE FORMAT & NUMBER:
BRAILLE TEXT:
ARTWORKER:
INKS:
TEMPLATE:
PR
JOB DESCRIPTION:
KEYLINE REFERENCE:
FONT USED:
NAME:
DATE:
APPROVED & PROCEED
AMEND & RE-SUBMIT
SIGNATURE:
OOF NUMBER:
3011
VIARTRIL
®
–S 500
Glucosamine Sulfate
Capsules 500 mg
NAME OF THE MEDICINAL PRODUCT
VIARTRIL
®
-S
COMPOSITION
Each capsule contains:
ACTIVE INGREDIENT
Crystalline Glucosamine sulfate
628 mg
Equivalent to:
glucosamine sulfate
500 mg
Sodium chloride
128 mg
EXCIPIENTS
Magnesium stearate, Talc.
PHARMACEUTICAL FORM AND PRESENTATION
Capsules. Package of 6, 60 and 90 capsules.
MANUFACTURER
ROTTAPHARM Ltd.
Damastown Industrial Park, Mulhuddart DUBLIN 15, IRELAND
THERAPEUTIC INDICATIONS
Treatment of the symptoms of osteoarthritis, i.e. pain and
function limitation.
CONTRA-INDICATIONS
Hypersensitivity to glucosamine or any of the excipients.
As the active ingredient is obtained from seafood (shellfish),
the product should not be given to patients who are allergic
to shellfish.
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
In asthmatic patients the product should be used with
caution as these patients could be more susceptible to
develop an allergic reactions to glucosamine with a possible
exacerbation of their symptoms.
The sodium content of oral formulations (151 mg for the
1500 mg daily dose) should be taken into consideration by
patients on a controlled sodium diet.
No special studies were performed in patients with renal or
hepatic insufficiency. The toxicological and pharmacokinetic
profile of the product does not indicate limitation for these
patients. However, administration to patients with severe
hepatic or renal insufficiency should be under medical
supervision.
Caution is advised in treatment of patients with impaired
glucose tolerance. Closer monitoring of blood sugar levels
may be necessary in diabetics at the begi